RecruitingPhase 3NCT07226882
A Study to Learn About Different Dosing Schedules of a Lyme Disease Vaccine in Healthy Adults
Studying Lyme disease
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Pfizer
- Principal Investigator
- Pfizer CT.gov Call CenterPfizer
- Intervention
- VLA15(biological)
- Enrollment
- 200 target
- Eligibility
- 18-44 years · All sexes
- Timeline
- 2025 – 2028
Study locations (5)
- Preferred Primary Care Physicians, Preferred Clinical Research (Ofc 18), Pittsburgh, Pennsylvania, United States
- Preferred Primary Care Physicians, Preferred Clinical Research-St. Clair, Pittsburgh, Pennsylvania, United States
- Preferred Primary Care Physicians, Uniontown, Pennsylvania, United States
- Clinical Research Partners, LLC, Richmond, Virginia, United States
- Amherst Family Practice, P.C., Winchester, Virginia, United States
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT07226882 on ClinicalTrials.govOther trials for Lyme disease
Additional recruiting or active studies for the same condition.
- RECRUITINGPHASE1, PHASE2NCT06785402Ceftriaxone for Post-Treatment Lyme DiseaseHackensack Meridian Health
- RECRUITINGPHASE4NCT06451913Effect of Saccharomyces Boulardii CNCM I-745 on Gut Microbiota in Patients Undergoing Antibiotic Therapy (in the Context of Erythema Migrans (Early Skin Form of Lyme Borreliosis))Biocodex
- RECRUITINGNANCT06915324Transcranial Direct Current Stimulation for Post Treatment Lyme DiseaseColumbia University
- RECRUITINGEARLY PHASE1NCT06611111Ceftriaxone Pulse Dose for Post-Treatment Lyme DiseaseState University of New York - Upstate Medical University
- ACTIVE NOT RECRUITINGNCT06835075Clinicaly Manifested Reinfections with Borrelia Burgdorferi Sensu LatoUniversity Medical Centre Ljubljana
- ACTIVE NOT RECRUITINGNCT06731179A Prospective Study to Evaluate the Role of T-Cell Dysfunction in Patients Who Present Symptoms Associated With Long COVID, Lyme Disease and Myalic Encephalomyelitis / Chronic Fatigue Syndrome Using the Vira Immune Fluorospot T Cell AssayViraxBio Labs
- RECRUITINGPHASE1, PHASE2NCT06511050Lumbrokinase for Adults With Long Covid, Post-treatment Lyme Disease Syndrome, and Myalgic Encephalomyelitis/Chronic Fatigue SyndromeIcahn School of Medicine at Mount Sinai
- RECRUITINGNANCT06655844Sana Device for Post-Treatment Lyme Disease Syndrome Chronic PainIcahn School of Medicine at Mount Sinai